Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-17-022382)

Filing Details

Accession Number:: 0001127602-17-022382
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-29 17:10:30
Reporting Period:: 2017-06-28

Filing Date:: 2017-06-29
Accepted Time:: 2017-06-29 17:10:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1681689	Bioverativ Inc.	BIVV	Pharmaceutical Preparations (2834)	813461310

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1696784	Diantha Duvall	225 2Nd Avenue Waltham MA 02451	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-28	818	$60.47	2,128	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.